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AES/GRG5: More Than Just a Dominant-
Negative TLE/GRG Family Member
Brandon Beagle
1,2 and Gail V.W. Johnson
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The human Transducin-like Enhancer of Split (TLE) and mouse homologue, Groucho gene-related protein
(GRG), represent a family of conserved non-DNA binding transcriptional modulatory proteins divided
into two subgroups based upon size. The long TLE/GRGs consist of four pentadomain proteins that are
dedicated co-repressors for multiple transcription factors (TF). The second TLE/GRG subgroup is com-
posed of the Amino-terminal Enhancer of Split (AES) in humans and its mouse homolog GRG5 (AES/
GRG5). In contrast to the dedicated co-repressor function of long TLE/GRGs, AES/GRG5 can both posi-
tively or negatively modulate various TF as well as non-TF proteins in a long TLE/GRG-dependent or -in-
dependent manner. Therefore, AES/GRG5 is a functionally dynamic protein that is not exclusively deﬁned
by its role as a long TLE/GRG antagonist. AES/GRG5 may function in various developmental and patho-
logical processes but the functional characteristics of endogenous AES/GRG5 in a physiologically relevant
context remains to be determined. Developmental Dynamics 239:2795–2805, 2010. V C 2010 Wiley-Liss, Inc.
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INTRODUCTION
The Groucho/TLE/GRG protein(s) are
a family of non-DNA binding co-fac-
tors that can interact with and medi-
ate the transcriptional activity of
DNA-binding transcription factors
(Fisher and Caudy, 1998; Chen and
Courey, 2000; Gasperowicz and Otto,
2005; Cinnamon and Paroush, 2008;
Jennings and Ish-Horowicz, 2008).
This transcriptional regulatory family
plays a critical role in numerous
developmental processes including
osteogenesis and neurogenesis (Muhr
et al., 2001; Wang et al., 2002, 2004;
Gasperowicz and Otto, 2005; Buscar-
let and Stifani, 2007). The Groucho/
TLE/GRG family was ﬁrst identiﬁed
in Drosophilia for which there exists
a single Groucho protein (Chen and
Courey, 2000; Gasperowicz and Otto,
2005). The human and mouse Groucho
homologs termed Transducin-like
Enhancer of Split (TLE) and Groucho
gene-related protein (GRG), respec-
tively consist of a family of proteins
that can be divided into two distinct
subgroups based upon their size (Chen
and Courey, 2000; Bajoghli, 2007).
The Long TLE/GRG subgroup con-
sists of four pentadomain proteins
(TLE1-4/GRG1-4) that function as
dedicated co-repressors for multiple
transcription factors (TF; Fig. 1;
Fisher and Caudy, 1998; Chen and
Courey, 2000; Gasperowicz and Otto,
2005; Bajoghli, 2007; Cinnamon and
Paroush, 2008; Jennings and Ish-Hor-
owicz, 2008; Jennings et al., 2008).
The long TLE/GRG proteins are com-
posed of a highly conserved amino-
terminal Q domain (protein interac-
tion and repression), followed by a GP
domain (protein interaction and repres-
sion), CcN domain (nuclear localization
signal, cdc2 and casein kinase II phos-
phorylation sites), an SP domain (pro-
tein interaction and repression) and a
highly conserved WD40 domain (TF
interaction; Miyasaka et al., 1993; Par-
khurst, 1998; Chen and Courey, 2000;
Brantjes et al., 2001; Courey and Jia,
2001; Gasperowicz and Otto, 2005;
Bajoghli, 2007; Jennings and Ish-Hor-
owicz, 2008). The Q domain mediates
interaction with TFs such as Tcf/Lef-1
as well as the tetramerization of long
TLE/GRG members, which is essen-
tial for their repressor function and
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1996; Cavallo et al., 1998; Chen et al.,
1998, 1999; Roose et al., 1998; Chen
and Courey, 2000; Brantjes et al., 2001;
Lopez-Rios et al., 2003; Song et al.,
2004; Gasperowicz and Otto, 2005;
Rave-Harel et al., 2005; Bajoghli, 2007;
O r i a ne ta l . ,2 0 0 7 ;S e k i y aa n dZ a r e t ,
2007; Arce et al., 2009; Zhang et al.,
2010). In addition to interacting with
various TFs such as Runx2 (Thiruna-
vukkarasu et al., 1998; McLarren
et al., 2000; Wang et al., 2004), the GP
domain of long TLE/GRGs interacts
with histone deacetylases (HDAC), a
mechanism by which long TLE/GRGs
mediate transcriptional repression
(Pinto and Lobe, 1996; Chen et al.,
1999; Choi et al., 1999; Chen and
Courey, 2000; Brantjes et al., 2001;
Courey and Jia, 2001; Yochum and
Ayer, 2001; Gregoretti et al., 2004;
Daniels and Weis, 2005; Gasperowicz
and Otto, 2005; Ye et al., 2009). The
long TLE/GRG proteins can also medi-
ate repression by blocking interaction
between co-activators and TFs (i.e.,
sterical hindrance; Courey and Jia,
2001; Daniels and Weis, 2005), initiat-
ing repressor complex formation
(Courey and Jia, 2001; Ju et al., 2004),
and inﬂuencing histone architecture/
chromatin structure (Palaparti et al.,
1997; Chen et al., 1999; Choi et al.,
1999; Courey and Jia, 2001; Yochum
and Ayer, 2001; Sekiya and Zaret,
2007). For a more in-depth review of
long TLE/GRG structure and function,
see Gasperowicz and Otto (2005) and
Chen and Courey (2000).
The second TLE/GRG subgroup is
composed of the Amino-terminal
Enhancer of Split (AES) in humans
and its mouse homolog GRG5 (Mallo
et al., 1993; Miyasaka et al., 1993;
Chen and Courey, 2000; Gasperowicz
and Otto, 2005; Bajoghli, 2007). The
AES/GRG5 proteins are truncated
family members (relative to the long
TLE/GRG members) as they consist
only of the Q and GP domains (Fig. 1;
Pinto and Lobe, 1996; Chen and
Courey, 2000; Brantjes et al., 2001;
Gasperowicz and Otto, 2005; Bajoghli,
2007). AES/GRG5 is not an alterna-
tively spliced variant of the long
TLE/GRG gene but is a distinct fam-
ily member expressed from its own
locus (Mallo et al., 1993; Miyasaka
et al., 1993; Mallo et al., 1995a; Gas-
perowicz and Otto, 2005; Bajoghli,
2007). There also exist truncated
TLE/GRG family members that result
from alternative splicing of the long
TLE/GRG gene (Leon and Lobe,
1997; Lepourcelet and Shivdasani,
2002; Milili et al., 2002; Gasperowicz
and Otto, 2005; Bajoghli, 2007) but
their function is less clear and will
not be discussed in this review. The Q
domain of AES/GRG5 and the long
TLE/GRG members both mediate mul-
timerization between AES/GRG5 and/
or long TLE/GRG proteins (Pinto and
Lobe, 1996; Grbavec et al., 1998; Ren
et al., 1999; Chen and Courey, 2000;
Tetsuka et al., 2000; Brantjes et al.,
2001; McLarren et al., 2001; Muhr
et al., 2001; Daniels and Weis, 2005;
Gasperowicz and Otto, 2005; Rave-
Harel et al., 2005; Zhang et al., 2008,
2010) as well as interactions with TFs
such as Tcf/Lef-1 (see Table 1; Brantjes
et al., 2001; Daniels and Weis, 2005;
Orian et al., 2007; Sekiya and Zaret,
2007). However, the GP domain of
AES/GRG5 and long TLE/GRG mem-
bers are conserved but functionally
distinct, as AES/GRG5 does not inter-
act with transcriptionally repressive
HDAC proteins (HDAC-1 and -3;
Brantjes et al., 2001; Yu et al., 2001;
Gasperowicz and Otto, 2005; Bajoghli,
2007; Zhang et al., 2008). Because
AES/GRG5 multimerizes with long
TLE/GRG members but does not
interact with HDACs, it is proposed
that long TLE/GRGs lose their ability
to form a functional, promoter/chro-
matin based tetrameric repressor
complex (Pinto and Lobe, 1996; Pala-
parti et al., 1997; Chen et al., 1998;
Choi et al., 1999; Chen and Courey,
2000; Brantjes et al., 2001; Yochum
and Ayer, 2001; Gasperowicz and
Otto, 2005). It is also possible that by
oligomerizing with long TLE/GRGs
(homotetramerization is required for
long TLE/GRGs to interact with cer-
tain TFs) long TLE/GRGs lose their
ability to interact with and repress cer-
tain TFs (Chen et al., 1998; Brantjes
et al., 2001; Song et al., 2004; Daniels
and Weis, 2005; Orian et al., 2007;
Sekiya and Zaret, 2007). A potential
result is that long TLE/GRGs are not
recruited to the promoter through
interaction with DNA-binding TFs
(Fisher and Caudy, 1998; Cinnamon
and Paroush, 2008). To date, no chro-
matin/DNA binding assays have been
conducted to determine if AES/GRG5
localizes to the promoter (long TLE/
GRG that possesses only the Q do-
main have been assayed; Sekiya and
Zaret, 2007) or decreases long TLE/
GRG:chromatin interaction. However,
sequestration from the promoter/
DNA-binding TF rather than antago-
nism of long TLE/GRGs at the pro-
moter/chromatin is partially sup-
ported by transcriptional assays
which show AES/GRG5 positively or
negatively modulates general tran-
scription if it is un-tethered or teth-
ered to the DNA (Mallo et al., 1995b;
Ren et al., 1999; Yu et al., 2001; Zhu
et al., 2002). Although the mecha-
nism(s) require further investigation/
validation, in vitro, in situ, and/or in
vivo data overexpressing/misexpress-
ing AES/GRG5 show AES/GRG5 can
antagonize transcriptional repression
and/or physiological effects mediated
by long TLE/GRGs in a context de-
pendent manner (Roose et al., 1998;
Chen and Courey, 2000; Wang et al.,
2000; Brantjes et al., 2001; Muhr et al.,
2001; Lopez-Rios et al., 2003; Swingler
et al., 2004; Wang et al., 2004; Bajoghli
et al., 2005; Gasperowicz and Otto,
2005; Rave-Harel et al., 2005; Allen
et al., 2006; Bajoghli, 2007; Bajoghli
et al., 2007; Zhang et al., 2008). There-
fore, AES/GRG5 has been classiﬁed as
a dominant-negative TLE/GRG family
member (Chen and Courey, 2000;
Brantjes et al., 2001; Muhr et al., 2001;
Lopez-Rios et al., 2003; Swingler et al.,
2004; Bajoghli et al., 2005; Gaspero-
wicz and Otto, 2005; Rave-Harel et al.,
2005; Allen et al., 2006; Bajoghli, 2007;
Bajoghli et al., 2007; Zhang et al.,
2008). However, cumulative analysis
o ft h ea v a i l a b l es t u d i e s( a sw i l lb e
discussed) suggests AES/GRG5 is a
dynamic protein whose biological
function is not exclusive to its deﬁned
role as a long TLE/GRG antagonist.
Although signiﬁcant data have
accumulated in the past few years,
AES/GRG5 remains a somewhat enig-
matic protein. This is due in part to the
varying models/systems, experimental
procedures, signaling and developmen-
tal pathways and protein interactions
used/analyzed across AES/GRG5 stud-
ies. Another confounding variable is
t h ef a c tt h a ta l m o s ta l lt h es t u d i e su s e
AES/GRG5 overexpression/misexpres-
sion. The overall focus of this review
will be on various aspects of the AES/
GRG5 protein including species
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and subcellular localization, protein
interactions and its physiological role
in development and disease. Although
studies have been carried out on AES/
GRG5 from various species, most have
focused on human AES and/or mouse
GRG5. Therefore, by default, this
review will focus on human AES and/
or mouse GRG5 unless noted.
EVOLUTION AND
CONSERVATION
AES/GRG-5 is highly conserved
among mammals as well as other
chordata such as Xenopus and zebra-
ﬁsh (Fig. 2; Chen and Courey, 2000;
Bajoghli, 2007). The conserved nature
of this protein is exempliﬁed by the
near perfect amino acid identity
between human AES and other mam-
mals such as mouse GRG5 (99%
sequence identity) and the nonmam-
malian vertebrate Xenopus AES (89%
sequence identity). This high degree
of conservation increases the validity
of extrapolating ﬁndings, especially
functional interaction data, obtained
with AES from one species (mostly
human AES and/or mouse GRG5) in a
more generalized context. However,
studies which focus on potential AES/
GRG5 interacting proteins sometimes
use different isoforms and proteins
from different species (see Table 1)
that are not as highly conserved and
thus caution needs to be exercised
when generalizing about the func-
tional outcomes. Finally, although
‘‘AES-like’’ proteins have been identi-
ﬁed using the Drosophilia expressed
sequence tag (EST) database (Chen
and Courey, 2000), their existence
and/or function has not been con-
ﬁrmed/investigated, to our knowledge.
Based upon a phylogenetic analysis
of the different TLE/GRG subgroups,
it is proposed AES/GRG5 arose from
tandem duplication of the long TLE2/
GRG2 gene (Bajoghli, 2007). Because
AES/GRG5 is expressed throughout
the phylum chordata (ex., human,
mouse, zebraﬁsh, Xenopus, etc), one
can speculate that the duplication
event took place before speciation.
According to the classic model of gene
duplication, the duplicate copy (i.e.,
AES/GRG5) persisted by acquiring
key alterations/mutations in its GP do-
main coding sequence which allowed
the AES/GRG5 protein to take on a
new function (called neo-functionaliza-
tion) as a dominant-negative member
of the TLE/GRG family (described ear-
lier; Bajoghli, 2007). Thus, it is specu-
lated that AES/GRG5 evolved from
the long TLE/GRG members (i.e.,
TLE2/GRG2) through mutation and
neo-functionalization (Bajoghli, 2007).
EXPRESSION AND
LOCALIZATION
Analysis of endogenous AES/GRG5
shows the 25 kDa protein is broadly
and constitutively expressed during
development and adulthood with
expression highest in muscle, heart,
placenta (AES) and brain (GRG5;
Mallo et al., 1993, 1995a; Miyasaka
et al., 1993; Brantjes et al., 2001;
Muhr et al., 2001; Zhu et al., 2002;
Jan et al., 2004; Wang et al., 2004;
Rave-Harel et al., 2005). However, de-
velopmental expression may be regu-
lated temporally in a tissue and/or in
a cell type dependent manner (Mallo
et al., 1993, 1995a; Muhr et al., 2001).
There are also data suggesting total
AES/GRG5 expression is tightly regu-
lated as GRG5 mice overexpressing
high, but not moderate levels of GRG5,
exhibit embryonic lethality (Allen et al.,
2006). According to the NCBI Entrez
database, three different transcripts/
protein-isoforms have been identiﬁed
for human AES: 1/a (1754 bp/266
amino acids; NP_945320.1), 2/b (1687
bp/197 amino acids; NP_001121.2)
and 3/c (1684 bp/196 amino acids;
NP_945321.1). Transcripts 2 and 3
were initially identiﬁed and differ
slightly in their 50 untranslated region
(UTR) as well as an internal deletion
of three nucleotides in transcript 3
(relative to transcript 2; Mallo et al.,
1993; Miyasaka et al., 1993). AES is
expressed from a single locus, there-
fore, it is speculated that the different
transcripts result from alternative
splicing and/or genetic polymorphism
(Miyasaka et al., 1993). As a result of
Fig. 1. Structure and homology for the Drosophilia Groucho, TLE, and/or GRG protein family.
The numbers above each box represent amino acid length for the domain identified at the top
of the figure. A,B: The boxed numbers represent % homology for the Q or GP domain of Droso-
philia Groucho or long GRG1-4 relative to GRG5 (A) Drosophilia Groucho or long TLE1-4 relative
to AES(B). Percentage homology was calculated using global alignment with BLOSUM 62 scoring
matrix. Amino acid sequence for the identified proteins are based upon the following NCBI acces-
sion numbers: Drosophilia Groucho (NP_733134), GRG1 (NP_035729.3), GRG2 (NP_062699.1),
GRG3 (NP_033415.1), GRG4 (NP_035730.2), GRG5 (NP_034477.1), TLE1 (NP_005068.2), TLE2
(NP_003251.2), TLE3 (NP_005069.2), TLE4 (NP_008936.2) and AES (NP_001121.2).
Fig. 2. Conservation of AES protein
sequence across species. Indicates percent
homology of the Q domain, GP domain or
entire AES protein for the indicated species
relative to human AES. GRG5 is equivalent to
mouse AES. Xenopus (x), Zebrafish (z), Rat (r).
Percent homology was calculated using global
alignment with BLOSUM 62 scoring matrix.
Amino acid sequence for the identified pro-
teins are based upon the following NCBI
accession numbers: AES (NP_001121.2),
GRG5 (NP_034477.1), rAES (NP_062093.1),
xAES (NP_001083532.1), zAES (NP_956717.1).
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protein isoform c (i.e., transcript 3) has
a single glutamine deletion at residue
126 (residue number based upon iso-
form b sequence). Transcript/protein
isoform 1/a is signiﬁcantly longer and
has a distinct N-terminus compared
with isoforms b and c. Although 1/a is
recognized as an AES variant in the
NCBI Entrez database, there are no
published data, to our knowledge, con-
ﬁrming its expression. In addition to
the 197 amino acid mouse GRG5, a
202 amino acid isoform was also iden-
tiﬁed (Mallo et al., 1993; Miyasaka
et al., 1993), but the 197 amino acid
GRG5 is the only isoform registered in
the NCBI Entrez database. Regard-
less, the 197 amino acid AES/GRG5
isoform is associated as the ‘‘canonical’’
AES/GRG5 protein (Choudhury et al.,
1997; Ren et al., 1999; Chen and
Courey, 2000; Tetsuka et al., 2000;
Brantjes et al., 2001; Yu et al., 2001;
Lopez-Rios et al., 2003; Gasperowicz
and Otto, 2005; Zhang et al., 2008) and
is the assumed isoform used by the
studies referred to in this review.
In contrast to long TLE/GRG pro-
teins, AES/GRG5 does not contain a
putative nuclear localization signal
(NLS) but is commonly referred to in
the literature as a nuclear protein
(Miyasaka et al., 1993; Mallo et al.,
1995a; Chen and Courey, 2000; Gas-
perowicz and Otto, 2005). Such classi-
ﬁcation is likely do to initial studies
showing endogenous GRG5 is exclu-
sively nuclear in NB41A3 neuroblas-
toma cells (Mallo et al., 1995a), com-
bined with the notion that AES/GRG5
functions as a transcriptional modula-
tory protein (i.e., nucleus). However,
it has also been shown that exogenous
AES can function in the cytosol (Jan
et al., 2004) which suggests AES/
GRG5 is not strictly a nuclear protein.
Indeed, analysis of the studies on ex-
ogenous and/or endogenous AES/
GRG5 (as well as Xenopus AES) sug-
gests subcellular distribution is inﬂu-
enced by cell type as it is exclusively
nuclear in some cells including gonad-
otropin hormone releasing neurons
(Mallo et al., 1995a; Zhu et al., 2002;
Rave-Harel et al., 2005; Zhang et al.,
2008), cytosolic in COS-7 cells (Cav-
allo et al., 1998; Roose et al., 1998)
and nucleocytoplasmic in cells includ-
ing HEK 293T cells (Jan et al., 2004;
Beagle and Johnson, 2010). AES/
GRG5 lacks a putative nuclear export
signal (NES) or NLS and, therefore,
regulation by the importin or exportin
family of proteins seems unlikely (Ull-
man et al., 1997). Although its rela-
tively small size ( 25 kDa) allows for
nuclear diffusion (Liu et al., 2005), it
is reasonable to assume the transcrip-
tional activity of various TFs is not
regulated by the random diffusion of
effector proteins such as AES/GRG5.
Therefore, what are the underlying
mechanism(s) that regulate AES/
GRG5 subcellular distribution? Using
Xenopus AES/GRG5 in COS-7 cells
(89% sequence identity to human
AES, see Fig. 2), one study showed
subcellular distribution is regulated
by certain Tcf (but not Lef-1) TFs
(Roose et al., 1998). It is speculated
that AES/GRG5 subcellular distribu-
tion might also be mediated by fellow
long TLE/GRG family members
(Chen and Courey, 2000). This sug-
gests AES/GRG5 localization is con-
text-dependent, therefore, differential
expression of AES/GRG5 interacting
proteins (ex. Tcf or long TLE/GRG;
Mallo et al., 1995a; Chen and Courey,
2000; Brantjes et al., 2001) might
explain why its subcellular distribu-
tion varies across cell lines. As will be
discussed, AES/GRG5 can modulate
the activity of various TF/non-TF pro-
teins (see Table 1). Therefore, AES/
GRG5 localization may serve as a reg-
ulatory mechanism by mediating
AES/GRG5’s ability to colocalize with
and modulate various TF/non-TF pro-
teins. Indeed, our lab has shown that
localization in part regulates exoge-
nous AES’s ability to positively modu-
late Lef-1 transcriptional activity in
HEK 293T cells (Beagle and Johnson,
2010). While further studies are
required to elucidate the regulatory
mechanism(s) that mediate endoge-
nous AES/GRG5 subcellular distribu-
tion, the data strongly suggest that
AES/GRG5 should not be classiﬁed, in
general, as a nuclear protein.
PROTEIN INTERACTIONS
Table 1 (adapted from Gasperowicz
and Otto, 2005) outlines the various
functional interactions, or lack
thereof, that have been identiﬁed
between TF/non-TF proteins and
AES/GRG5 (as well as other AES spe-
cies). Table 1 also includes a brief
description, when possible, summa-
rizing how the identiﬁed interactions
effect the TF/non-TF protein activity
and/or AES/GRG5 activity as well as
the physiological/biological affect. It
should be noted that all functional
interaction data are based upon over-
expression/misexpression of AES/
GRG5 and, therefore, caution must be
used in extrapolating to physiological
conditions. Although both long TLE/
GRG and AES/GRG5 protein(s) inter-
act with many of the same proteins,
how they interact with, as well as the
ability to interact with certain TF/
non-TF proteins differs. As expected,
TFs that interact exclusively with the
C-terminal SP and WD40 domains of
the long TLE/GRGs, do not interact
with AES/GRG5 due to the lack of
these domains (Chen and Courey,
2000; Eberhard et al., 2000; McLar-
ren et al., 2001; Gasperowicz and
Otto, 2005; Bajoghli, 2007). However,
there are TFs such as the androgen
receptor (AR) and Six4 that can inter-
act with the Q domain of AES but not
the Q domain of a full-length long
TLE-2 or -3 protein (Lopez-Rios et al.,
2003; Zhang et al., 2010). Subse-
quently, it was shown the C-terminal
domains (CcN, SP, and/or WD40) of
long TLE/GRG proteins actually block
interaction with such TFs as AR and
Six4 (Lopez-Rios et al., 2003; Zhang
et al., 2010). Similarly, a series of ele-
gant experiments involving AES-
mediated AR repression also revealed
a novel intramolecular regulatory
mechanism for AES (Zhang et al.,
2010). First, it was shown that inter-
molecular AES homodimerization,
mediated by residues 1–129 of the Q
domain, is required for it to interact
with and inhibit AR transcriptional
activity. This homodimerization do-
main located within the AES protein
(classiﬁed as the AR inhibitory do-
main) can intramolecularly interact
w/ residues 156–176 of AES (classiﬁed
as the negative regulatory domain)
and prevent intermolecular homodi-
merization between AES proteins.
However, residues 190–193 of AES
(classiﬁed as the positive regulatory
domain) prevents intramolecular
interaction between residues 1–129/
156–176 within the AES protein (i.e.,
AR inhibitory domain/negative regu-
latory domain) thereby allowing AES
intermolecular homodimerization and
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ﬁnding as Q domain-mediated homo-
and/or hetero-oligomerization is
believed to play a critical role in AES/
GRG5s ability to antagonize long
TLE/GRGs as well as positively mod-
ulate transcription factors such as
Tcf/Lef-1 (see Introduction for more
details; Roose et al., 1998; Brantjes
et al., 2001; Daniels and Weis, 2005;
Beagle and Johnson, 2010). Future
studies should be conducted to deter-
mine if the described intramolecular
regulatory mechanism is a general or
TF/non-TF speciﬁc AES regulatory
mechanism.
Interestingly, data suggest that
AES/GRG5 does not act as a general
negative regulator of long TLE/GRGs
as neither GRG5 nor AES antagonize
long GRG4-mediated Pax5 (Eberhard
et al., 2000) or long TLE-mediated
Hes1 (McLarren et al., 2001) tran-
scriptional repression. Because AES/
GRG5 does not interact with TFs
such as Hes1 (McLarren et al., 2001)
it is speculated AES/GRG5 might
only exert a dominant-negative effect
over long TLE/GRGs when both fam-
ily subgroups can interact with spe-
ciﬁc DNA-binding TFs, such as Runx2
(Thirunavukkarasu et al., 1998;
Wang et al., 2004). However, this
notion conﬂicts with data showing
both AES and long TLE1 can interact
with and repress NF-kB-mediated
transcriptional activity (Tetsuka
et al., 2000). Also, GRG5 can antago-
nize long GRG-mediated PRH tran-
scriptional repression even though
GRG5 does not interact with PRH
(Swingler et al., 2004). These exam-
ples clearly show that the mecha-
nism(s) by which AES/GRG5 antago-
nizes long TLE/GRGs activity needs
to be investigated further.
Such examples also serve to illus-
trate the fact that AES/GRG5, unlike
the long TLE/GRG proteins, is not a
dedicated TF co-repressor. In con-
trast, AES/GRG5 can positively or
negatively modulate various TFs as
well as non-TF proteins (see Table 1).
The fact that AES can repress TFs
such as AR (Yu et al., 2001; Zhang
et al., 2010) and NF-kB (Tetsuka
et al., 2000) clearly shows that AES/
GRG5 does not function exclusively
as an antagonist of long TLE/GRG
repressor activity. For example, AES
but not full length long TLE-2 or -3,
mediates AR repression by preventing
AR:DNA interaction (Zhang et al.,
2010). AES/GRG5 might also be capa-
ble of directly modulating transcrip-
tion independent of long TLE/GRG
family members as AES was shown to
interact with TFIIE, a basal TF (Yu
et al., 2001). The functional impact of
an AES:TFIIE interaction has not
been explored but it was speculated
that AES negatively regulates basal
transcription through TFIIE interac-
tion (Yu et al., 2001). However, the
same study also showed AES
enhanced GAL4-VP16-mediated tran-
scription of a recombinant template
that required TFIIE (in addition to
other basic transcriptional compo-
nents). Further, AES/GRG5 also plays
a role in cellular processes not
directly associated with transcription,
unlike the long TLE/GRG proteins.
By interacting with cytosolic Bit1, a
proapoptotic protein, AES was shown
to promote anoikis (i.e., cell detach-
ment)-mediated apoptosis (Jan et al.,
2004). Taken as a whole, data suggest
AES/GRG5 is a multifunctional pro-
tein whose biological activity is not
based solely upon its ability to antago-
nize long TLE/GRG proteins.
In addition to localization, AES/
GRG5 activity is regulated through
interactions with non-TF proteins
such HDAC-related protein (HDRP;
Zhang et al., 2008) and the soluble in-
tracellular domain of the LRP6 recep-
tor (LRP6-ICD; Beagle and Johnson,
2010). HDRP (an HDAC1 interacting
protein) does not affect AES localiza-
tion but may repress AES dominant-
negative activity over long TLE1
thereby allowing long TLE1-mediated
repression of proapoptotic genes
(Zhang et al., 2008). Because AES
does not interact with HDAC1 (Yu
et al., 2001; Zhang et al., 2008), it also
suggest that AES does not exist in a
complex with HDRP:HDAC1. There-
fore, it would be interesting to see
how AES effects the transcriptional
repressive activity mediated by the
HDRP:HDAC1 interaction. Nonethe-
less, data suggest that AES/GRG5 ac-
tivity is also regulated, in addition to
localization, through interaction with
other proteins (Zhang et al., 2008;
Beagle and Johnson, 2010).
While informative, most functional
interaction data are derived from cell
culture and animal based assays
involving overexpression/misexpression
of exogenous AES/GRG5. However,
AES/GRG5 developmental expression
is temporally restricted in a cell type/
tissue dependent manner (Mallo et al.,
1993, 1995a; Muhr et al., 2001), there-
fore, the physiological effect mediated
by certain functional interactions may
not be relevant. For example, GRG4-
mediated Nkx transcriptional repres-
sion establishes progenitor cell pattern
and neuronal fate in the ventral neural
tube, a phenotype deﬁned in a tempo-
rally relevant manner (Muhr et al.,
2001). Overexpressing/misexpressing
GRG5 can mitigate the neuronal phe-
notype by antagonizing GRG4-medi-
ated Nkx transcriptional repression
but the same study also showed en-
dogenous GRG5 is not developmen-
tally expressed at the relevant time
point (Muhr et al., 2001). Therefore,
the potential physiological effect of
AES/GRG5-mediated functional inter-
actions should be carefully examined
in the context of endogenous protein
expression in a physiologically rele-
vant context.
ROLE IN DEVELOPMENT
AND DISEASE
The TLE/GRG family mediates
expression of numerous developmen-
tal genes that are regulated by tran-
scriptional signaling pathways such
as the Wnt/b-catenin pathway (Chen
and Courey, 2000; Brantjes et al.,
2001; Bajoghli et al., 2005, 2007; Gas-
perowicz and Otto, 2005; Buscarlet
and Stifani, 2007; Cinnamon and
Paroush, 2008). As a result, the TLE/
GRG family plays an essential role in
numerous developmental processes.
AES/GRG5 activity has been impli-
cated in developmental processes
including hematopoeisis (Swingler
et al., 2004), ear development (Aghaal-
laei et al., 2005; Bajoghli et al., 2005),
heart formation (Bajoghli et al., 2007),
puberty (Rave-Harel et al., 2005), pi-
tuitary gland development (Brinkme-
ier et al., 2003), and Xenopus axis for-
mation (Roose et al., 1998) to name a
few. Although the above processes
have been tentatively studied, the ma-
jority of in vivo studies have focused
on the functional role of AES/GRG5 in
growth and osteogenesis, as well as
eye development, which we will dis-
cuss below.
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sThe Runx2 TF is required for differ-
entiation and function of osteoblast
(Wang et al., 2002, 2004). Interaction
and functional assays in cell culture
and Runx2
þ/ GRG5
 /  mice suggest
GRG5 enhances Runx2 transcrip-
tional activity in vivo to regulate post-
natal growth in mice (Wang et al.,
2004). The lack of GRG5 activity sig-
niﬁcantly potentiated defective mem-
branous bone formation in Runx2 het-
erozygotes and caused a severe long
bone growth plate defect. The bone
and cartilage defects were associated
with reduced Indian hedgehog (Ihh)
expression which mediates bone and
cartilage development (Wang et al.,
2002, 2004). The developmental
defects and reduced Ihh activity were
only seen in Runx2
þ/ GRG5
 /  (not
Runx2
þ/ GRG5
þ/þ) mice which sug-
gest GRG5 effects Ihh activity
through Runx2 (Wang et al., 2002,
2004). In addition to Runx2, AES/
GRG5 might also inﬂuence postnatal
skeletal growth through Tcf4 and
Lef1 which are expressed in skeletal
tissue and whose activity is modu-
lated by AES/GRG5 and the long
TLE/GRGs (Roose et al., 1998; Hart-
mann and Tabin, 2000; Brantjes
et al., 2001; Daniels and Weis, 2005;
Cinnamon and Paroush, 2008; Beagle
and Johnson, 2010). Regulation of AR
activity may serve an additional
mechanism by which AES/GRG5 can
affect postnatal growth properties
(skeletal and/or nonskeletal) (Yu
et al., 2001; Frenkel et al., 2010;
Zhang et al., 2010).
Six3 and Six6 are DNA-binding TFs
required for eye development, medi-
ated in part by interaction with TLE/
GRG proteins (Kobayashi et al., 2001;
Zhu et al., 2002; Lopez-Rios et al.,
2003). AES and GRG5 (in addition to
Groucho, long TLE1 and/or GRG4)
were shown to interact with Six3 and/
or Six6 by means of GST pulldown
and yeast two hybrid studies (Zhu
et al., 2002; Lopez-Rios et al., 2003).
Although Drosophilia Groucho and
long GRG4 were shown to interact
with Six3 by means of co-immunopre-
cipitation in NIH3T3 mammalian
cells, this interaction could not be
detected for GRG5 (Zhu et al., 2002).
Expression patterns of exogenous
and/or endogenous medaka (rice ﬁsh)
AES or GRG5 was also shown to over-
lap with Six3 and Six6 in the develop-
ing medaka eye (Lopez-Rios et al.,
2003) or Six3 in the mouse embryo as
well as colocalize in NIH3T3 cells
(Zhu et al., 2002). Through modula-
tion of Six3 and/or Six6, in vivo data
suggest exogenous AES/GRG5 activ-
ity plays a critical role in certain
aspects of eye development (Zhu
et al., 2002; Lopez-Rios et al., 2003).
Reporter assays show that GRG5 can
enhance Six3 activity which is
required for early eye development
(Zhu et al., 2002). Although no differ-
ence in lens morphogenesis and crys-
tallin regulation was seen between
chick embryos overexpressing Six3
alone or with GRG5, there are data
suggesting GRG5 can modulate Six3-
mediated retinogenic formation in
postnatal mice (Zhu et al., 2002). It
should be noted that in this study, a
mutant Six3 expression construct
incapable of binding either long GRGs
or GRG5 was used and thus these
ﬁndings require further validation
(Zhu et al., 2002). The observation is
supported however in medaka ﬁsh
overexpressing human AES which
showed AES can modulate Six3- and
Six6-mediated expression of ectopic
retina tissue (Lopez-Rios et al., 2003).
The cell culture and in vivo expres-
sion patterns, interaction and func-
tional assays strongly suggest AES/
GRG5 modulates eye development by
means of Six3 and/or Six6. However,
additional functional assays involving
endogenous AES/GRG5 are required
to better deﬁne AES/GRG5s role in
eye development and its role relative
to that of the long TLE/GRGs.
Similar to long TLE/GRGs, AES/
GRG5 may be involved in nondevelop-
mental processes, as it has been
implicated in various pathological
conditions including cancer. For
example, a GRG1/GRG5 transgenic
mouse model showed GRG5 overex-
pression reduced tumor burden due to
GRG1 overexpression induced lung
adenocarcinoma (Allen et al., 2006).
Furthermore, AES functions as a
proapoptotic protein (in a context de-
pendent manner) by antagonizing the
antiapoptotic effects mediated by
TLE1 (Jan et al., 2004; Zhang et al.,
2008), whose elevated expression is
associated with certain cancers such
as lymphoma (Shipp et al., 2002). In
addition to its role in osteogenesis,
Runx2, a TF positively or negatively
modulated by GRG5 or long TLE/
GRGs (Thirunavukkarasu et al.,
1998; Wang et al., 2004; Gasperowicz
and Otto, 2005), functions as a potent
tumor suppressor (Baniwal et al.,
2009). Negative modulation of AR ac-
tivity, whose aberrant activity is com-
monly associated with prostate can-
cer, similarly suggests a role for AES/
GRG5 in certain cancers independent
of its dominant-negative activity over
long TLE/GRG proteins (Yu et al.,
2001; Baniwal et al., 2009; Zhang
et al., 2010). Taken as a whole, the
data reveal a potential anti-oncogenic
function for AES/GRG5 in a long
TLE/GRG-dependent (i.e., dominant-
negative activity) as well as -inde-
pendent manner. The ability to inﬂu-
ence osteocyte activity through Runx2
(and potentially AR) indicates AES/
GRG5 can inﬂuence other pathologi-
cal processes including bone disorders
such as osteoporosis (Baniwal et al.,
2009; Frenkel et al., 2010). Regulation
of immunomodulatory TFs such as
NF-kB (Tetsuka et al., 2000) and
PRDI-BF1 (Ren et al., 1999) suggest
an immunological function for AES/
GRG5, a potential physiological role
that can be further explored in the
various transgenic mouse models
used in the ﬁeld of immunology.
The described functional data
strongly suggest AES/GRG5 imparts
signiﬁcant and broad physiological ac-
tivity in both development and adult-
hood. However, extreme caution is
required when interpreting the ani-
mal and functional interaction data.
First, the GRG5 mice, generated by
targeted disruption of the GRG5 al-
lele, exhibit only transient growth re-
tardation (Mallo et al., 1995a; Wang
et al., 2002, 2004). While one study
showed 20% of GRG5 null mice ex-
hibit growth retardation severe
enough to cause death (Mallo et al.,
1995a), data show most GRG5 null
mice are viable and their overall
growth is at least 80% that of their
control littermates (Mallo et al.,
1995a; Wang et al., 2002, 2004). In
the absence of decreased co-factor
expression (ex. Runx2), the data sug-
gest GRG5 is dispensable for appro-
priate terminal growth (i.e., adult
body weight) as well as terminal skel-
etal and chondral development. It is
interesting to note that the effect on
terminal growth as well as growth
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was less severe for the female GRG5
null mice compared with the GRG5
null male mice (Wang et al., 2002,
2004). Reasons for the gender differ-
ence remain to be investigated. While
GRG5 null mice are fertile (Mallo
et al., 1995a; Wang et al., 2002;
although Runx2
þ/ GRG5
 /  mice
are infertile; Wang et al., 2004) with
some abnormal reproductive behavior
(Mallo et al., 1995a), most studies
focused only on body weight, skeletal,
and/or chondral properties. One of the
studies did not ﬁnd any reproducible
pathology in the GRG5 null mice upon
‘‘extensive histopathological analyses’’
but a description of the analyses was
not provided (Mallo et al., 1995a).
However, one GRG5 null study focus-
ing exclusively on mouse pituitary de-
velopment showed abnormal pituitary
gland enlargement (Brinkmeier et al.,
2003). Unfortunately, the study only
focused on embryonic day (E) 14.5,
E16.5 and postnatal day 1, therefore,
the long-term consequences, if any, on
pituitary development and/or function
are unknown. As a result, it is not
clear what effect, if any, loss of GRG5
has on the phenotype of other traits
(ex. immune function, tissue homeo-
stasis, etc) in development and/or
adulthood. Second, the described func-
tional interactions and/or effects
mediated by AES/GRG5 are based
upon exogenous AES/GRG5 that is
overexpressed/misexpressed in vari-
ous cell culture and/or animal based
assays. Therefore, to determine the
physiological relevance of AES/GRG5
in development and/or adulthood,
caution must be used when critically
examining the current research. With
that said, the ubiquitous expression
of endogenous AES/GRG5 combined
with the described functional data
does suggest AES/GRG5 is a physio-
logically relevant protein. Targeted
inactivation of genes such as retinoic
acid receptor-a (Li et al., 1993; Cam-
mas et al., 2010) and transglutami-
nase 2 (De Laurenzi and Melino, 2001;
Nanda et al., 2001), thought to be im-
portant for a wide variety of functions,
have very mild or even no phenotypic
consequences. For many of the
described AES/GRG5 functional inter-
actions such as NF-kB( T e t s u k ae ta l . ,
2000) and Runx2 (Baniwal et al.,
2009), the interacting TF/non-TF ac-
tivity is regulated by other factors.
The lack of an obvious terminal pheno-
type in the GRG5 null mice might,
therefore, be a result of functional re-
dundancy mediated by other regula-
tory/interacting protein. Another plau-
sible reason (not mutually exclusive) is
AES/GRG5 may not be acting as a pri-
mary controller, but rather as a modu-
latory regulatory protein. AES/GRG5’s
physiological impact may, therefore, be
more subtle and not as readily eluci-
dated. Determining AES/GRG5’s phys-
iological signiﬁcance will ultimately
require analysis of endogenous AES/
GRG5 in a physiologically relevant
manner.
PERSPECTIVE
The TLE/GRG family consists of tran-
scriptional modulatory proteins that
play a critical role in numerous devel-
opmental as well as homeostatic proc-
esses. While the transcriptional re-
pressive function of long TLE/GRGs
has been extensively deﬁned (relative
to AES/GRG5), the dynamic proper-
ties exhibited by AES/GRG5 make it a
more difﬁcult protein to classify. AES/
GRG5 is classically identiﬁed as a
dominant-negative TLE/GRG family
member that functions to antagonize
long TLE/GRG repressor activity. How-
ever, a review of the functional interac-
tions modulated by AES/GRG5 overex-
pression/misexpression shows AES/
GRG5 can also function in a long TLE/
GRG independent manner. In contrast
to the long TLE/GRG proteins which
function as dedicated transcriptional
repressors, the reviewed data show
AES/GRG5 can inﬂuence transcrip-
tional and nontranscriptional events
by positively or negatively regulating/
effecting/modulating various TF and
non-TF proteins (see Table 1). Cumu-
lative analysis of the available data,
therefore, strongly suggests AES/
GRG5’s functional activity should not
be relegated to its dominant-negative
classiﬁcation.
The context-dependent dominant-
negative activity of AES/GRG5 has
well been studied, yet the mechanism
by which AES/GRG5 antagonizes long
TLE/GRGs is not clear and requires
further investigation/validation. Is
AES/GRG5 sequestering long TLE/
GRGs from the promoter based TF
and/or inhibiting the promoter/chro-
matin based repressor function of
long TLE/GRGs through lack of
HDAC recruitment? What additional
mechanism(s) does AES/GRG5 modu-
late the transcriptional activity of
TFs in a manner independent of long
TLE/GRG antagonism? Can AES/
GRG5 inﬂuence transcription through
the basal transcriptional machinery
(i.e., TFIIE), effect recruitment of co-
activator or -repressor complexes and/
or effect TF promoter binding? Delin-
eation of such questions should help
clarify and more accurately classify
AES/GRG5s functional role within
the TLE/GRG family as well as its
context dependent cellular function.
AES/GRG5 is unique in that it can
functionally interact with cytosolic
and nuclear localized TF/non-TF pro-
teins. Although endogenous AES/
GRG5 expression is ubiquitous, its
subcellular distribution varies in a
cell type dependent manner and that
differential localization functions in
part, to regulate AES/GRG5 activity.
There are data suggesting AES/GRG5
localization is mediated by proteins
whose activity in turn is modulated
by AES/GRG5. Therefore, it is possi-
ble that differential expression of
such proteins explains the cell type
dependent subcellular distribution of
AES/GRG5. Although the regulatory
mechanism(s) that mediate its local-
ization requires signiﬁcant investiga-
tion and validation, the data clearly
show AES/GRG5 subcellular classiﬁ-
cation should be deﬁned according to
cell type as opposed to its classic
description as a nuclear protein.
In conclusion, AES/GRG5 is capable
of functionally interacting with
numerous TF/non-TF proteins and,
therefore, has the potential to inﬂu-
ence numerous cellular/physiological
processes. There are data suggesting
AES/GRG5 in conjunction with other
co-factors plays a critical role in devel-
opmental processes such as growth
and eye development as well as patho-
logical processes including cancer.
Although informative, the described
studies almost exclusively involve cell
culture and animal based assays in
which exogenous AES/GRG5 is being
overexpressed/misexpressed. While en-
dogenous AES/GRG5 expression is
widespread in the adult, future AES/
GRG5 studies should conﬁrm the inter-
action and/or co-expression between
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sendogenous AES/GRG5 and interact-
ing TF/non-TF proteins as well as the
physiological process being studied (if
applicable). This is especially impor-
tant when analyzing the developmen-
tal effects mediated by AES/GRG5 as
expression is temporally restricted.
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